You shouldnt take semaglutide if: You or a family member has a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
In everyday use, GLP-1 receptor agonists like Semaglutide and Tirzepatide often yield weight loss results comparable to those seen in clinical trials
Additionally, semaglutide has been shown to decrease glucagon secretion, a hormone that raises blood glucose levels, further contributing to its glucose-lowering effects
Patients using the LillyDirect platform can reference the tirzepatide dosing guide to ensure they order the correct dose tier
Narrator: Thats it for todays show
Its interactions arise primarily through two mechanisms: pharmacodynamic effects (additive or opposing actions on the body) and pharmacokinetic effects (alterations in how medicines are absorbed, metabolised, or eliminated)